Microbiome dysbiosis and its modulation in cancer development, prevention and therapy - Top-Institutions - MDSpire

Microbiome dysbiosis and its modulation in cancer development, prevention and therapy

  • By

  • Shivendra Dixit

  • Antonia Welker

  • Diego Ortiz

  • Marina Athanasouli

  • Christoph K. Stein-Thoeringer

  • July 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

Microbiome dysbiosis and its modulation in cancer development, prevention and therapy

  • by Shivendra Dixit, Antonia Welker, Diego Ortiz, Marina Athanasouli, Christoph K. Stein-Thoeringer

  • July 2, 2026

Related Content

ERCC6L in human cancers: oncogenic functions, molecular mechanisms, and clinical implications as a prognostic biomarker and therapeutic target

Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer

A novel bimanual endoluminal robotic platform compatible with standard gastroscopes for endoscopic submucosal dissection: preclinical feasibility and ergonomic evaluation